Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Acadia Pharmaceuticals (ACAD) Q2 2017 Earnings
ACAD
+0.86%
9
May
Confirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
-0.73
-0.66
-0.58
-0.51
Details
Expected EPS
-0.73
Actual EPS
-0.72
Surprise EPS
0.01
Surprise Percent
+1.37%
Description
Acadia Pharmaceuticals (ACAD) has reported earnings of -0.72 per share for Q2 2017.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login